These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32770710)

  • 1. Epigenetic Changes Associated With Anthracycline-Induced Cardiotoxicity.
    Tantawy M; Pamittan FG; Singh S; Gong Y
    Clin Transl Sci; 2021 Jan; 14(1):36-46. PubMed ID: 32770710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
    Bozza WP; Takeda K; Alterovitz WL; Chou CK; Shen RF; Zhang B
    AAPS J; 2021 Mar; 23(2):44. PubMed ID: 33719006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
    Ghigo A; Li M; Hirsch E
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy.
    Nishi M; Wang PY; Hwang PM
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2648-2660. PubMed ID: 34587760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline-induced cardiotoxicity: An overview from cellular structural perspective.
    Li H; Wang M; Huang Y
    Biomed Pharmacother; 2024 Oct; 179():117312. PubMed ID: 39167843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
    Henriksen PA
    Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiotoxicity of anthracyclines].
    Costache II; Petriş A
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1200-7. PubMed ID: 22276470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression.
    Dong Q; Chen L; Lu Q; Sharma S; Li L; Morimoto S; Wang G
    Br J Pharmacol; 2014 Oct; 171(19):4440-54. PubMed ID: 24902966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside.
    Li Y; Lin R; Peng X; Wang X; Liu X; Li L; Bai R; Wen S; Ruan Y; Chang X; Tang R; Liu N
    Oxid Med Cell Longev; 2022; 2022():3659278. PubMed ID: 36187332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal evaluation of oxidative stress - mitochondrial dysfunction - ferroptosis genes in anthracycline-induced cardiotoxicity.
    Qianqian R; Peng Z; Licai Z; Ruizhi Z; Tianhe Y; Xiangwen X; Chuansheng Z; Fan Y
    BMC Cardiovasc Disord; 2024 Jul; 24(1):350. PubMed ID: 38987722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?
    Sawyer DB; Peng X; Chen B; Pentassuglia L; Lim CC
    Prog Cardiovasc Dis; 2010; 53(2):105-13. PubMed ID: 20728697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
    Chung WB; Youn HJ
    Korean J Intern Med; 2016 Jul; 31(4):625-33. PubMed ID: 27378126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens.
    Cadeddu Dessalvi C; Pepe A; Penna C; Gimelli A; Madonna R; Mele D; Monte I; Novo G; Nugara C; Zito C; Moslehi JJ; de Boer RA; Lyon AR; Tocchetti CG; Mercuro G
    Heart Fail Rev; 2019 Nov; 24(6):915-925. PubMed ID: 31256318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3K27ac acts as a molecular switch for doxorubicin-induced activation of cardiotoxic genes.
    Hong Y; Li X; Li J; He Q; Huang M; Tang Y; Chen X; Chen J; Tang KJ; Wei C
    Clin Epigenetics; 2024 Jul; 16(1):91. PubMed ID: 39014511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?
    Dempke WCM; Zielinski R; Winkler C; Silberman S; Reuther S; Priebe W
    Eur J Cancer; 2023 May; 185():94-104. PubMed ID: 36966697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of anthracycline cardiovascular toxicity.
    Narezkina A; Narayan HK; Zemljic-Harpf AE
    Clin Sci (Lond); 2021 May; 135(10):1311-1332. PubMed ID: 34047339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.